Adma Biologics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Stocks That Made New Highs On Friday, Aug. 19
Article By: Fred Fuld
Sunday, August 21, 2022 5:46 AM EST
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.
In this article: NL, ARTNA, ICPT, SUPN, ADMA, AXSM
Read
4 Drug/Biotech Stocks Set To Outpace Q4 Earnings Estimates
Article By: Zacks Investment Research
Saturday, February 20, 2021 9:00 AM EST
While almost all big drugmakers have reported their results, several smaller drug and biotech companies are yet to report this earnings season.
In this article: LXRX, MRNA, ADMA, BNTX Also: AVIR
Read
ADMA Biologics Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Saturday, June 9, 2018 2:00 AM EST
ADMA Biologics, Inc. announced today the pricing of its previously announced underwritten public offering of 8,368,200 shares of its common stock at a public offering price of $4.78 per share.
In this article: ADMA
Read
ADMA Biologics: Almost Ready To Run Between The Toes Of Giants
Article By: Simon Daly
Tuesday, March 6, 2018 10:27 PM EST
ADMA’s lead product candidate has positive data, positioned for high unmet medical need. The burden of lifting regulatory hold is lower than might be perceived by investors at present.
In this article: ADMA
Read
ADMA Biologics Announces Pricing Of Follow-On Offering
Article By: NASDAQ GlobeNewswire
Thursday, November 9, 2017 11:27 AM EST
ADMA Biologics, Inc. today announced the pricing of an underwritten public offering of approximately 17.0 million shares of its common stock at a public offering price of $2.15 per share, representing gross proceeds of approximately $36.5 million.
In this article: ADMA
Read

Latest Tweets for $ADMA

No tweets yet!

PARTNER HEADLINES